Rocket Pharmaceuticals, Inc.
Total Awards:
3
Award Value:
$12,685,820
Institution type:
For profit
Short Name:
Rocket Pharmaceuticals, Inc.
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Dr. Jonathan Schwartz | A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease | $5,808,735 |
| Clinical Trial Stage Projects | Dr. Gayatri Rao | A Phase I Clinical Trial for a Lentiviral Gene Therapy Targeting the TCIRG1 Gene for Infantile Malignant Osteopetrosis (IMO) | $1,010,000 |
| Clinical Trial Stage Projects | Dr. Kinnari Patel | LADICell | $5,867,085 |
| Total: $12,685,820.00 |
